First in Human, Dose Escalation, Dose Expansion Study of AUR105
Clinical trial NCT05605119 · TERMINATED
Trial details
- NCT number
- NCT05605119
- Sponsor
- Aurigene Discovery Technologies Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2024-03-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.